DAVIO-2 for wet AMD and VERONA for DME. In the DAVIO-2 trial, patients previously treated with approximately 10 injections in ...
The American Academy of Ophthalmology (AAO) is hosting its annual scientific meeting in Orlando, Florida from October 17 ...
A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, ...
The 18-month extension of the GATHER2 trial indicated continued benefit for patients receiving avacincaptad pegol, with ...
Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting, the Eye Care Network spoke with Peter Stalmans, MD, PhD, ...
The study analyzed real-world treatment patterns and safety of avacincaptad pegol (ACP) for geographic atrophy using the IRIS ...
STAAR responded by saying, “We urge all STAAR stockholders not to be misled by Broadwood. STAAR is confident that the Alcon transaction maximizes value for STAAR stockholders [and] is the only merger ...
Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting in Orlando, Florida, the Eye Care Network spoke with Jean-Francois Korobelnik, MD. Prof Korobelnik, of Hôpital Pellegrin and CHU de ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
Avisi Technologies’ investigational device exemption (IDE) submission for its glaucoma treatment device VisiPlate has been approved by the US Food and Drug Administration (FDA).
Rayner's RayOne EMV Toric IOL received FDA approval after a successful pivotal IDE study, highlighting its rotational ...
Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback